Rocket Lab Corporation (Nasdaq: RKLB) reported results for the third quarter ended September 30, 2026, on November 9, 2026. Revenue reached a record $267.8 million, up 73% year-over-year and above the prior guidance range of $250–265 million, marking the sixth consecutive record quarter. Backlog expanded 52% sequentially to a record $3.57 billion, supported by roughly $1 billion in new launch contracts (including more than $515 million for Neutron) and $470 million in Space Systems awards.
Neutron’s first launch has been delayed to 2027 due to a manufacturing defect in carbon-composite propellant tank domes, while the company guided to another record revenue quarter in Q4.
| Metric | Q3 2026 Estimate | Q3 2026 Result | Q4 2026 Estimate / Guidance | Notes / Guidance |
|---|---|---|---|---|
| Revenue | ~$257–258M | $267.8M (+73% YoY) | $270–290M | Beat prior Q3 guide of $250–265M |
| EPS (GAAP) | ~($0.07) | ($0.12) | n/a | Miss driven by higher opex & Neutron spend |
| Adj. EBITDA | n/a | –$18.0M | –$14M to –$20M | Within prior Q3 range of –$17M to –$23M |
| GAAP Gross Margin | 29–31% (prior guide) | 33.6% | 34–36% | Exceeded prior guide |
| Non-GAAP Gross Margin | 35–37% (prior guide) | 38.4% | 39–41% | Exceeded prior guide |
| Backlog | n/a | $3.57B (+52% QoQ) | n/a | ~$1.17B expected within 12 months; 117 launches |
| Cash & Liquidity | n/a | ~$4.45B cash; ~$4.7B total cash + securities | n/a | Bolstered by ATM equity offering |
| Operating Cash Flow | n/a | +$7.2M | n/a | Positive; non-GAAP FCF still negative |
Actual Results: Sixth Consecutive Record Revenue Quarter and Sharp Backlog Expansion
- Total revenue of $267.8 million rose 73% year-over-year and approximately 14% sequentially, exceeding both consensus and the company’s prior guidance of $250–265 million.
- Space Systems contributed $214.8 million (up 13% sequentially and roughly 88% year-over-year), driven by satellite platform scaling and a full quarter of contributions from recent acquisitions (including Mynaric laser communications and robotics assets). Launch Services revenue was $53.1 million (up 19% sequentially), reflecting six Electron missions with revenue recognized at launch.
- GAAP gross margin of 33.6% and non-GAAP gross margin of 38.4% both exceeded the prior guidance ranges, though both declined sequentially due to mix (full-quarter Mynaric contribution) and the absence of prior-quarter tariff refunds.
- Adjusted EBITDA loss of $18.0 million was within the previously guided range of –$17 million to –$23 million. GAAP net loss widened to $79.7 million, or ($0.12) per share, reflecting elevated operating expenses ($169.3 million GAAP) from acquisition-related costs and higher Neutron development spending.
- Backlog reached a record $3.57 billion, up 52% from $2.36 billion at the end of Q2, with approximately $1 billion in new Electron, HASTE, and Neutron launch contracts plus $470 million in Space Systems awards. Neutron’s contracted backlog grew to 16 missions, including eight new deals signed in the quarter at an escalated base price of $70 million.
- GAAP operating cash flow turned positive at $7.2 million. The company ended the quarter with approximately $4.45 billion in cash and cash equivalents (roughly $4.7 billion including marketable securities), supported by an at-the-market equity offering that generated about $2.4 billion in gross proceeds.
Why It Matters: Demand Strength and Pricing Power Offset Neutron Timeline Slip
- The combination of a revenue beat, sequential growth across both segments, and a 52% backlog increase demonstrates sustained commercial and defense demand for Rocket Lab’s end-to-end offerings. The ability to sign more than $515 million in Neutron contracts (bringing the first 16 launches fully contracted) and raise the base price to $70 million on several missions indicates pricing power even as the vehicle’s debut has slipped.
- Neutron’s first launch has been pushed from a prior Q4 2026 target to 2027 after the discovery of voids (air pockets) in carbon-composite forward propellant tank domes during manufacturing. Management has stated the root cause has been identified and mitigated, with a replacement dome in production and further testing expected into early 2027 before a refined launch date is set. Contracts include cancellation fees, reducing near-term revenue risk.
- Margin outperformance versus guidance, despite the intentional mix shift toward lower-margin satellite platforms and acquisition contributions, supports underlying operational efficiency in the core business. Positive operating cash flow in the quarter is a notable improvement, though elevated Neutron investment is expected to keep free cash flow negative near term.
- The substantial liquidity position provides a multi-year runway to fund Neutron development, production scale-up, and integration of recent acquisitions without immediate capital constraints.
What’s Ahead: Another Record Quarter and Strategic Transformation
- Management guided Q4 2026 revenue of $270–290 million (another record), GAAP gross margin of 34–36%, non-GAAP gross margin of 39–41%, and an adjusted EBITDA loss of $14–20 million.
- Neutron development and certification remain the primary focus, with first flight targeted for 2027 and critical hardware milestones continuing at Launch Complex 3. Management expects to complete key tank assembly and testing into early 2027 before setting a more precise launch date.
- The company anticipates continued strong bookings and backlog conversion, with a significant portion of the current $3.57 billion backlog expected to convert within the next 12 months.
- Integration of recent acquisitions (including progress toward the previously announced Iridium transaction, which has received key approvals) continues alongside ongoing Electron cadence and Space Systems scaling.
Risks to Forward Expectations: Margin Mix, Integration, and Execution
- Neutron development and certification timelines remain the central execution risk. Further delays beyond 2027 would postpone medium-lift revenue contribution, extend elevated R&D and manufacturing investment, and pressure near-term free cash flow and investor sentiment.
- Near-term gross margins are expected to face ongoing mix headwinds from a higher proportion of satellite platforms and acquisition-related amortization, even as absolute margins have exceeded recent guidance.
- Adjusted EBITDA losses are projected to continue in Q4 amid sustained Neutron spending and integration costs. GAAP operating expenses have run above prior guidance ranges.
- High valuation relative to current profitability leaves the stock sensitive to any further Neutron slippage, guidance misses, or slower-than-expected backlog conversion.
- Successful integration of acquisitions (Mynaric, Motiv, and the pending Iridium deal) carries execution, cultural, and synergy risks.
Bottom Line: Record Scale and Backlog Visibility, with Neutron Timing the Key Variable
Rocket Lab delivered a strong operational quarter, with record revenue, sequential growth in both Launch Services and Space Systems, margin outperformance versus guidance, and a sharply expanded $3.57 billion backlog that includes meaningful Neutron commitments at higher pricing. The delay of Neutron’s first flight to 2027 is a clear setback for the medium-lift timeline, but contracted demand and demonstrated pricing power reduce the immediate commercial impact.
With roughly $4.7 billion in liquidity and a multi-year backlog providing visibility, the company is well positioned to fund continued investment. Sustained execution on Electron cadence, Space Systems scaling, acquisition integration, and—most critically—Neutron development and certification will determine the pace at which Rocket Lab converts its end-to-end platform into durable profitability and larger-scale market share.
